Back to funds

Soleus Capital Management, L.P.

hedge fundUpdated 30 days ago

Managed by Soleus Capital Management, L.P. • Latest filing Q2 2026

Portfolio value
$2.9B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
45.5%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 14 quarters

Show data table
PeriodPortfolio value
Q1 2023$965.7M
Q2 2023$899.5M
Q3 2023$1.1B
Q4 2023$901.2M
Q1 2024$1.3B
Q2 2024$1.1B
Q3 2024$1.3B
Q4 2024$1.6B
Q1 2025$1.4B
Q2 2025$1.5B
Q3 2025$2B
Q4 2025$2.7B
Q1 2026$2.5B
Q2 2026$2.9B

Top holdings

97 positions as of Q2 2026

View filing
K

KRYSTAL BIOTECH INC

Value
$349.1M
Shares
939.3K
% Port
12.03%
C

CELCUITY INC

Value
$178.3M
Shares
1.70M
% Port
6.14%
T

TG THERAPEUTICS INC

Value
$160.9M
Shares
2.93M
% Port
5.54%
P

INSULET CORP

Value
$159.7M
Shares
1.05M
% Port
5.50%
N

NOVOCURE LTD

Value
$150.2M
Shares
9.91M
% Port
5.18%
U

UNITED THERAPEUTICS CORP DEL

Value
$122.2M
Shares
225.6K
% Port
4.21%
I

INSPIRE MED SYS INC

Value
$86.2M
Shares
1.93M
% Port
2.97%
R

RIGEL PHARMACEUTICALS INC

Value
$72.1M
Shares
1.84M
% Port
2.49%
A

ANI PHARMACEUTICALS INC

Value
$71.8M
Shares
867.8K
% Port
2.48%
B

BETA BIONICS INC

Value
$68.8M
Shares
4.39M
% Port
2.37%
V
11.VCEL

VERICEL CORP

Value
$64.9M
Shares
1.46M
% Port
2.24%
P
12.PRAX

PRAXIS PRECISION MEDICINES I

Value
$59.4M
Shares
177.5K
% Port
2.05%
G
13.GERN

GERON CORP

Value
$54.8M
Shares
42.81M
% Port
1.89%
A
14.ALKS

ALKERMES PLC

Value
$53.9M
Shares
1.03M
% Port
1.86%
E
15.EQR

ERASCA INC

Value
$49.5M
Shares
2.70M
% Port
1.70%
N
16.NPCE

NEUROPACE INC

Value
$46.3M
Shares
2.91M
% Port
1.59%
P
17.PGNY

PROGYNY INC

Value
$46.2M
Shares
1.60M
% Port
1.59%
I
18.INDV

INDIVIOR PHARMACEUTICALS INC

Value
$43.7M
Shares
1.06M
% Port
1.50%
P
19.PBLS

PARABILIS MEDICINES INC

Value
$40.1M
Shares
1.47M
% Port
1.38%
F
20.FOCL

EDAP TMS S A

Value
$37.9M
Shares
7.31M
% Port
1.30%

Explore